Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1M Buy
18,834,883
+1,174,900
+7% +$1.79M 1.48% 20
2025
Q4
$23.3M Buy
17,659,983
+5,060,981
+40% +$6.35M 1.17% 21
2025
Q3
$17.3M Buy
12,599,002
+5,278,828
+72% +$7.03M 1.19% 23
2025
Q2
$10.3M Buy
+7,320,174
New +$10.4M 0.95% 32

Other funds holding GERN

Eversept Partners's GERN Position: Q1 2026 in Review

Eversept Partners increased its Geron (GERN) stake by 6.7% in Q1 2026, buying an estimated $1.79M and bringing the position to 18,834,883 shares worth $28.1M. The position accounts for 1.48% of the portfolio, ranked #20.

Eversept Partners first reported a position in GERN in Q2 2025 and has held it in 4 quarters since. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.

  • Eversept Partners held 18,834,883 shares of Geron worth $28.1M as of Q1 2026.
  • Eversept Partners bought 1,174,900 Geron shares in Q1 2026, an estimated $1.79M.
  • Geron made up 1.48% of Eversept Partners's portfolio in Q1 2026, its #20 holding.
  • Eversept Partners first reported a position in Geron in Q2 2025 and has held it in 4 quarters since.
  • 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.